AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cboe Global Markets
CBOE
|
+$1.07B |
| 2 |
Applovin
APP
|
+$455M |
| 3 |
Broadcom
AVGO
|
+$450M |
| 4 |
AXON
Axon Enterprise
AXON
|
+$442M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$440M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$1.6B |
| 2 |
Walt Disney
DIS
|
+$795M |
| 3 |
Idexx Laboratories
IDXX
|
+$692M |
| 4 |
Zoetis
ZTS
|
+$640M |
| 5 |
Microsoft
MSFT
|
+$615M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.02% |
| 2 | Healthcare | 12.31% |
| 3 | Consumer Discretionary | 11.7% |
| 4 | Financials | 11.01% |
| 5 | Communication Services | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKYA
3151
DELISTED
Akoya BioSciences
AKYA
| $75.7K | ﹤0.01% |
33,050
| – | – |
|
3152
eGain
EGAN
$187M
| $75.1K | ﹤0.01% |
12,060
| – | – |
|
3153
Outdoor Holding Co
POWW
$250M
| $74.4K | ﹤0.01% |
67,600
| – | – |
|
3154
Traeger
COOK
$170M
| $74.2K | ﹤0.01% |
621
| – | – |
|
3155
Zura Bio
ZURA
$511M
| $72.1K | ﹤0.01% |
28,840
| – | – |
|
3156
Verastem
VSTM
$534M
| $71.8K | ﹤0.01% |
13,880
| – | – |
|
3157
BuzzFeed
BZFD
$94.1M
| $71.6K | ﹤0.01% |
26,823
| – | – |
|
3158
Eve Holding
EVEX
$860M
| $71.4K | ﹤0.01% |
13,120
| – | – |
|
|
TUYA
3159
Tuya Inc
TUYA
$1.01B
| $71.3K | ﹤0.01% |
39,820
| – | – |
|
3160
Tenaya Therapeutics
TNYA
$167M
| $70.9K | ﹤0.01% |
49,570
| – | – |
|
3161
HF Foods Group
HFFG
$81.8M
| $69.8K | ﹤0.01% |
21,760
| – | – |
|
3162
PLAYSTUDIOS Inc
MYPS
$78.4M
| $69.8K | ﹤0.01% |
37,520
| – | – |
|
3163
Biote Corp
BTMD
$70.7M
| $67.8K | ﹤0.01% |
10,970
| – | – |
|
3164
Wheels Up
UP
$219M
| $67.5K | ﹤0.01% |
2,046
| – | – |
|
|
CVAC
3165
DELISTED
CureVac
CVAC
| $67.1K | ﹤0.01% |
19,691
| – | – |
|
3166
PepGen
PEPG
$131M
| $66.9K | ﹤0.01% |
17,650
| – | – |
|
|
CLPR
3167
Clipper Realty
CLPR
$46.4M
| $64.3K | ﹤0.01% |
14,030
| – | – |
|
3168
Trevi Therapeutics
TRVI
$2.57B
| $63.6K | ﹤0.01% |
15,440
| – | – |
|
3169
Banco Santander
SAN
$200B
| $62.6K | ﹤0.01% |
+13,720
| New | +$65.9K |
|
3170
Solid Biosciences
SLDB
$777M
| $62.4K | ﹤0.01% |
15,600
| – | – |
|
3171
Taboola.com
TBLA
$1.35B
| $62K | ﹤0.01% |
17,000
| – | – |
|
3172
Accuray
ARAY
$26.8M
| $61.2K | ﹤0.01% |
30,930
| – | – |
|
3173
Telos
TLS
$346M
| $60.8K | ﹤0.01% |
17,780
| – | – |
|
|
FSP
3174
Franklin Street Properties
FSP
$45.7M
| $59.3K | ﹤0.01% |
32,390
| – | – |
|
3175
Getty Images
GETY
$173M
| $58.4K | ﹤0.01% |
27,020
| – | – |
|
Similar funds
AllianceBernstein's Q4 2024 Portfolio in Review
As of Q4 2024, AllianceBernstein held 3,298 positions worth $295B, down 1% from $298B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 4.4%. AllianceBernstein opened 67 new positions and exited 77, leaving the 3,298-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AllianceBernstein's largest Q4 2024 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,000,000 shares worth $157M.
- AllianceBernstein added most to Cboe Global Markets in Q4 2024, an estimated $1.07B increase.
- AllianceBernstein's biggest Q4 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $1.6B.
- AllianceBernstein fully exited iShares US Treasury Bond ETF in Q4 2024, selling an estimated $176M.
- AllianceBernstein's ten largest holdings make up 30% of its $295B portfolio in Q4 2024.
- AllianceBernstein opened 67 new positions and closed 77 in Q4 2024.
- AllianceBernstein's portfolio value fell 1% quarter-over-quarter to $295B.
Based on AllianceBernstein's 13F filing for Q4 2024, filed 12 Feb 2025.